Chandrakasan, S., Allen, C. E., Bhatla, D., Carter, J., Chien, M., Cooper, R., Draper, L., Eckstein, O. S., Hanna, R., Hays, J. A., Hermiston, M. L., Hinson, A. P., Hobday, P. M., Isakoff, M. S., Jordan, M. B., Leiding, J. W., Modica, R., Nakano, T. A., … Oladapo, A. (2025). Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summary. Immunotherapy, 17(7), 461–478. https://doi.org/10.1080/1750743x.2025.2509478

SahBandar, I. N., Maegawa, G. H. B., Brandman, D., Rand, J. H., Lim, H. I., & Geyer, J. T. (2024). A diagnosis of non‐neuronopathic and late‐onset acid sphingomyelinase deficiency (Niemann‐Pick disease A/B) following bone marrow biopsy showing foamy histiocytosis. EJHaem, 5(5), 1078–1079. Portico. https://doi.org/10.1002/jha2.1003

Chandrakasan, S., Allen, C. E., Bhatla, D., Carter, J., Chien, M., Cooper, R., Draper, L., Eckstein, O. S., Hanna, R., Hays, J. A., Hermiston, M. L., Hinson, A. P., Hobday, P. M., Isakoff, M. S., Jordan, M. B., Leiding, J. W., Modica, R., Nakano, T. A., … Oladapo, A. (2024). Emapalumab Treatment in Patients With Rheumatologic Disease–Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study. Arthritis & Rheumatology. Portico. https://doi.org/10.1002/art.42985

DeFilipp, Z., Kim, H. T., Spyrou, N., Katsivelos, N., Kowalyk, S., Eng, G., Kasikis, S., Beheshti, R., Baez, J., Akahoshi, Y., Ayuk, F., Choe, H., Etra, A., Grupp, S. A., Hexner, E. O., Hogan, W. J., Kitko, C. L., Qayed, M., Reshef, R., … Chen, Y.-B. (2024). The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD. Blood Advances, 8(13), 3488–3496. https://doi.org/10.1182/bloodadvances.2024012561

Nishiyama, S., Seok, J. M., Wright, A. E., Lotan, I., Mikami, T., Drosu, N. C., Bobrowski-Khoury, N., Anderson, M. R., Bilodeau, P. A., Schindler, P., Paul, F., Aoki, M., Yeaman, M. R., Levy, M., Behne, J. M., Behne, M. K., Bennett, J. L., Blaschke, T. F., … Chitnis, T. (2024). Anti-aquaporin-4 immune complex stimulates complement-dependent Th17 cytokine release in neuromyelitis optica spectrum disorders. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-53661-5

Sekulic, M., Batal, I., Kudose, S., Santoriello, D., Stokes, M. B., Jim, B., Marti, H.-P., Eikrem, Ø., Radhakrishnan, J., D’Agati, V. D., & Markowitz, G. S. (2024). Kidney Dysfunction and Pathology in the Setting of Hemophagocytic Lymphohistiocytosis. Kidney International Reports, 9(2), 410–422. https://doi.org/10.1016/j.ekir.2023.10.033

Schanberg, L. E., Mulugeta, L. (Yeruk), Akinlade, B., Brunner, H. I., Chen, J., Colbert, R. A., Delgaizo, V., Gastonguay, M. R., Glaser, R., Imundo, L., Lovell, D. J., Leu, J. H., Mostafa, N. M., Nelson, R. M., Nigrovic, P. A., Nikolov, N. P., Rider, L. G., Rothwell, R., Sahajwalla, C., … Yao, L. (2023). Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis: Extrapolation, Dose Selection, and Clinical Trial Design. Arthritis & Rheumatology, 75(10), 1856–1866. Portico. https://doi.org/10.1002/art.42534

Askanase, A. D., Aranow, C., Kim, M. Y., Kamen, D. L., Arriens, C., Khalili, L., Tang, W., Barasch, J., Dall’Era, M., & Mackay, M. (2023). Protocol for virtual physical examination in an observational, longitudinal study evaluating virtual outcome measures in SLE. Lupus Science & Medicine, 10(2), e000952. https://doi.org/10.1136/lupus-2023-000952

McNerney, K. O., Si Lim, S. J., Ishikawa, K., Dreyzin, A., Vatsayan, A., Chen, J. J., Baggott, C., Prabhu, S., Pacenta, H. L., Philips, C., Rossoff, J., Stefanski, H. E., Talano, J.-A., Moskop, A., Verneris, M., Myers, D., Karras, N. A., Brown, P., Bonifant, C. L., … Schultz, L. M. (2023). HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL. Blood Advances, 7(12), 2758–2771. https://doi.org/10.1182/bloodadvances.2022008893

Solomon, D. H., Giles, J. T., Liao, K. P., Ridker, P. M., Rist, P. M., Glynn, R. J., Broderick, R., Lu, F., Murray, M. T., Vanni, K., Santacroce, L. M., Abohashem, S., Robson, P. M., Fayad, Z., Mani, V., Tawakol, A., & Bathon, J. (2022). Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 82(3), 324–330. https://doi.org/10.1136/ard-2022-223302

Azab, B., Rabab’h, O., Aburizeg, D., Mohammad, H., Dardas, Z., Mustafa, L., Khasawneh, R. A., Awad, H., Hatmal, M. M., & Altamimi, E. (2022). Potential Composite Digenic Contribution of NPC1 and NOD2 Leading to Atypical Lethal Niemann-Pick Type C with Initial Crohn’s Disease-like Presentation: Genotype-Phenotype Correlation Study. Genes, 13(6), 973. https://doi.org/10.3390/genes13060973

DiFranza, L. T., & Santoriello, D. (2021). Acute Kidney Injury in a Patient on High-dose Glucocorticoid Therapy. Kidney360, 2(10), 1686–1687. https://doi.org/10.34067/kid.0003072021

Wang, R., Dasgupta, A., & Ward, M. M. (2022). Predicting Probability of Response to Tumor Necrosis Factor Inhibitors for Individual Patients With Ankylosing Spondylitis. JAMA Network Open, 5(3), e222312. https://doi.org/10.1001/jamanetworkopen.2022.2312